Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Debra L Friedman

Showing results (121-130 of 176) with videos related to

Pageof 18
Sort By:
International Journal of Cancer|December 2, 2009
Secondary malignant neoplasms after Wilms tumor: an international collaborative studyNorman E Breslow, Jane M Lange, Debra L Friedman, et al.
Pediatric Blood & Cancer|October 28, 2016
Childhood Hodgkin International Prognostic Score (CHIPS) Predicts event-free survival in Hodgkin Lymphoma: A Report from the Children's Oncology GroupCindy L Schwartz, Lu Chen, Kathleen McCarten, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 22, 2023
Accumulation of Chronic Disease Among Survivors of Childhood Cancer Predicts Early MortalityAdam J Esbenshade, Lu Lu, Debra L Friedman, et al.
European Journal of Cancer (Oxford, England : 1990)|June 30, 2020
Survivorship in immune therapy: Assessing toxicities, body composition and health-related quality of life among long-term survivors treated with antibodies to programmed death-1 receptor and its ligandJames Randall Patrinely, Arissa C Young, Henry Quach, et al.
JAMA|January 30, 2009
Breast cancer surveillance practices among women previously treated with chest radiation for a childhood cancerKevin C Oeffinger, Jennifer S Ford, Chaya S Moskowitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2006
Risk of selected subsequent carcinomas in survivors of childhood cancer: a report from the Childhood Cancer Survivor StudyMylène Bassal, Ann C Mertens, Leslie Taylor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 15, 2014
Dose-intensive response-based chemotherapy and radiation therapy for children and adolescents with newly diagnosed intermediate-risk hodgkin lymphoma: a report from the Children's Oncology Group Study AHOD0031Debra L Friedman, Lu Chen, Suzanne Wolden, et al.
Experimental Eye Research|January 14, 2021
Intravitreal melphalan hydrochloride vs propylene glycol-free melphalan for retinoblastoma vitreous seeds: Efficacy, toxicity and stability in rabbits models and patientsCarley M Bogan, Janene M Pierce, Stephanie D Doss, et al.
The New England Journal of Medicine|October 13, 2006
Chronic health conditions in adult survivors of childhood cancerKevin C Oeffinger, Ann C Mertens, Charles A Sklar, et al.
Blood|October 18, 2021
A gene expression-based model predicts outcome in children with intermediate-risk classical Hodgkin lymphomaRebecca L Johnston, Anja Mottok, Fong Chun Chan, et al.
Pageof 18

Showing results (121-130 of 176) with videos related to

Sort By:
Pageof 18
International Journal of Cancer|December 2, 2009
Secondary malignant neoplasms after Wilms tumor: an international collaborative studyNorman E Breslow, Jane M Lange, Debra L Friedman, et al.
Pediatric Blood & Cancer|October 28, 2016
Childhood Hodgkin International Prognostic Score (CHIPS) Predicts event-free survival in Hodgkin Lymphoma: A Report from the Children's Oncology GroupCindy L Schwartz, Lu Chen, Kathleen McCarten, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 22, 2023
Accumulation of Chronic Disease Among Survivors of Childhood Cancer Predicts Early MortalityAdam J Esbenshade, Lu Lu, Debra L Friedman, et al.
European Journal of Cancer (Oxford, England : 1990)|June 30, 2020
Survivorship in immune therapy: Assessing toxicities, body composition and health-related quality of life among long-term survivors treated with antibodies to programmed death-1 receptor and its ligandJames Randall Patrinely, Arissa C Young, Henry Quach, et al.
JAMA|January 30, 2009
Breast cancer surveillance practices among women previously treated with chest radiation for a childhood cancerKevin C Oeffinger, Jennifer S Ford, Chaya S Moskowitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2006
Risk of selected subsequent carcinomas in survivors of childhood cancer: a report from the Childhood Cancer Survivor StudyMylène Bassal, Ann C Mertens, Leslie Taylor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 15, 2014
Dose-intensive response-based chemotherapy and radiation therapy for children and adolescents with newly diagnosed intermediate-risk hodgkin lymphoma: a report from the Children's Oncology Group Study AHOD0031Debra L Friedman, Lu Chen, Suzanne Wolden, et al.
Experimental Eye Research|January 14, 2021
Intravitreal melphalan hydrochloride vs propylene glycol-free melphalan for retinoblastoma vitreous seeds: Efficacy, toxicity and stability in rabbits models and patientsCarley M Bogan, Janene M Pierce, Stephanie D Doss, et al.
The New England Journal of Medicine|October 13, 2006
Chronic health conditions in adult survivors of childhood cancerKevin C Oeffinger, Ann C Mertens, Charles A Sklar, et al.
Blood|October 18, 2021
A gene expression-based model predicts outcome in children with intermediate-risk classical Hodgkin lymphomaRebecca L Johnston, Anja Mottok, Fong Chun Chan, et al.
Pageof 18